Prime award
OSIVAX · Department of Health and Human Services
OXIVAX - AOI #28: INFLUENZA VACCINE INNOVATION. ADVANCING METAGENOMIC NEXT-GENERATION SEQUENCING BASED AGNOSTIC DIAGNOSTICS FOR VIRAL PATHOGENS THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PREPARE THE IND PACKAGE FOR OVX836+SQ ADJUVANT.
Current value$744K
Obligated to date$0
Months remaining6
Sign in to mark this as watching, pursuing, or passed — and to be told when its end date changes.
Recompete signal
This award ends in 6 months and drew a single offer last time.
Award record
| Field | Value |
|---|---|
| Recipient | OSIVAX |
| Awarding agency | Department of Health and Human Services |
| NAICS | 541714 |
| PSC | AN14 |
| Period | → Mar 31, 2027 |
| Set-aside | NO SET ASIDE USED. |
| Competition | A |
| Offers received | 1 offer |
| Vehicle | Standalone |
Data & sources
Record as published by USAspending.gov, vintage FY2021–FY2025 full archives · USAspending.gov, retrieved Aug 6, 2026. Values change as modifications are reported; obligations may be negative when work is de-obligated.